Bristol-Myers Squibb Company
RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR
Last updated:
Abstract:
The present invention relates to radiolabeled LPA1 receptor antagonists of Formula (I) or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein, which are useful for the quantitative imaging of LPA1 receptors in mammals. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
14 Oct 2019
Issue date:
9 Dec 2021